James E. Whitman

1.5k total citations
26 papers, 1.0k citations indexed

About

James E. Whitman is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, James E. Whitman has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 11 papers in Oncology and 10 papers in Infectious Diseases. Recurrent topics in James E. Whitman's work include Cytomegalovirus and herpesvirus research (14 papers), Viral-associated cancers and disorders (8 papers) and Parvovirus B19 Infection Studies (6 papers). James E. Whitman is often cited by papers focused on Cytomegalovirus and herpesvirus research (14 papers), Viral-associated cancers and disorders (8 papers) and Parvovirus B19 Infection Studies (6 papers). James E. Whitman collaborates with scholars based in United States, Germany and Finland. James E. Whitman's co-authors include Dharam V. Ablashi, Louise G. Chatlynne, Ethel Cesarman, Eugene B. Buynak, M. R. Hilleman, Gary R. Pearson, Joseph Stokes, Robert E. Weibel, Mark H. Kaplan and William Lapps and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

James E. Whitman

25 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Whitman United States 14 721 507 313 169 106 26 1.0k
Claudia Gandolfo Italy 17 183 0.3× 106 0.2× 335 1.1× 35 0.2× 52 0.5× 49 855
Philippe Monteyne Belgium 16 320 0.4× 86 0.2× 154 0.5× 120 0.7× 14 0.1× 32 761
Margaret Haire United Kingdom 16 319 0.4× 100 0.2× 118 0.4× 139 0.8× 9 0.1× 47 714
O Picard France 20 490 0.7× 120 0.2× 250 0.8× 51 0.3× 3 0.0× 48 1.1k
Zohar Ravid Israel 8 216 0.3× 143 0.3× 93 0.3× 48 0.3× 4 0.0× 13 563
S Roedenbeck United States 6 328 0.5× 28 0.1× 162 0.5× 66 0.4× 42 0.4× 7 516
Sueli Donizete Borelli Brazil 14 318 0.4× 104 0.2× 150 0.5× 156 0.9× 2 0.0× 61 828
Henry F. Pabst Canada 14 247 0.3× 71 0.1× 69 0.2× 21 0.1× 90 0.8× 30 778
Imelda Lindo de Soriano United States 7 363 0.5× 28 0.1× 183 0.6× 65 0.4× 40 0.4× 7 540
T. Gotlieb‐Stematsky Israel 12 166 0.2× 129 0.3× 212 0.7× 62 0.4× 3 0.0× 48 568

Countries citing papers authored by James E. Whitman

Since Specialization
Citations

This map shows the geographic impact of James E. Whitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Whitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Whitman more than expected).

Fields of papers citing papers by James E. Whitman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Whitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Whitman. The network helps show where James E. Whitman may publish in the future.

Co-authorship network of co-authors of James E. Whitman

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Whitman. A scholar is included among the top collaborators of James E. Whitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Whitman. James E. Whitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chatlynne, Louise G., et al.. (2003). Human Herpesvirus 8 Infection Among Various Population Groups in Southern Israel. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(5). 500–505. 6 indexed citations
2.
Ablashi, Dharam V., Louise G. Chatlynne, James E. Whitman, & Ethel Cesarman. (2002). Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases. Clinical Microbiology Reviews. 15(3). 439–464. 215 indexed citations
3.
Ablashi, Dharam V., Jacqueline Friedman, John B. Zabriskie, et al.. (2000). Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. Journal of Clinical Virology. 16(3). 179–191. 143 indexed citations
4.
Ablashi, Dharam V., Louise G. Chatlynne, David L. Thomas, et al.. (2000). Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma.. Blood. 96(6). 2304–6. 13 indexed citations
5.
Strickler, Howard D., James J. Goedert, Florian Bethke, et al.. (1999). Human Herpesvirus 8 Cellular Immune Responses in Homosexual Men. The Journal of Infectious Diseases. 180(5). 1682–1685. 26 indexed citations
6.
Friedman, Jacqueline, Michael J. Lyons, James E. Whitman, et al.. (1999). The association of the human herpesvirus-6 and MS. Multiple Sclerosis Journal. 5(5). 355–362. 93 indexed citations
7.
Ablashi, D. V., John G. Bernbaum, Louise G. Chatlynne, et al.. (1998). Propagation and characterization of human herpesvirus-7 (HHV-7) isolates in a continuous T-lymphoblastoid cell line (SupT1). Journal of Virological Methods. 73(2). 123–140. 13 indexed citations
8.
Ablashi, Dharam V., et al.. (1998). HHV-6 Infection in HIV-Infected Asymptomatic and AIDS Patients. Intervirology. 41(1). 1–9. 22 indexed citations
9.
10.
Wagner, Mathias, et al.. (1998). Chronic fatigue syndrome (CFS): Review of clinical data from 107 cases. 61(4). 195–210.
11.
Ablashi, D. V., Louise G. Chatlynne, William Lapps, et al.. (1997). HUMAN HERPESVIRUS-8 (HHV-8). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). A23–A23. 4 indexed citations
12.
Ablashi, Dharam V., Paul H. Levine, Caterina De Vinci, et al.. (1996). Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy. 9(1-3). 81–86. 3 indexed citations
13.
Asano, Yukio, et al.. (1996). Development and application of HHV-6 antigen capture assay for the detection of HHV-6 infections. Journal of Virological Methods. 61(1-2). 103–112. 11 indexed citations
14.
Wagner, Mathias, G. R. F. Krueger, Dharam V. Ablashi, & James E. Whitman. (1996). Chronic Fatigue Syndrome (CFS): A Critical Evaluation of Testing for Active Human Herpesvirus-6 (HHV-6) Infection. Journal of Chronic Fatigue Syndrome. 2(4). 3–16. 15 indexed citations
15.
Ablashi, Dharam V., et al.. (1995). Viruses and Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome. 1(2). 4–22. 11 indexed citations
16.
Whitman, James E., et al.. (1981). Purification of Human Lymphoblastoid Cell-Derived Interferon-Alpha by Controlled-Pore Glass Bead Adsorption Chromatography and Molecular Sieving*. Journal of Interferon Research. 1(2). 305–313. 12 indexed citations
17.
Whitman, James E., et al.. (1980). LARGE‐SCALE PURIFICATION OF HUMAN FIBROBLAST INTERFERON FOR ANTIVIRAL AND ANTIPROLIFERATIVE STUDIES. Annals of the New York Academy of Sciences. 350(1). 599–600. 1 indexed citations
18.
Whitman, James E., et al.. (1975). An Unusual Case of Feline Leukemia and an Associated Syncytium-Forming Virus. American Journal of Veterinary Research. 36(7). 873–880. 9 indexed citations
19.
Weibel, Robert E., et al.. (1969). Jeryl Lynn strain live mumps virus vaccine.. JAMA. 207(9). 1 indexed citations
20.
Hilleman, M. R., Robert E. Weibel, Eugene B. Buynak, Joseph Stokes, & James E. Whitman. (1967). Live, Attenuated Mumps-Virus Vaccine. New England Journal of Medicine. 276(5). 252–258. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Gandolfo Breakdown of academic impact, for papers by Philippe Monteyne Breakdown of academic impact, for papers by Margaret Haire Breakdown of academic impact, for papers by O Picard Breakdown of academic impact, for papers by Zohar Ravid Breakdown of academic impact, for papers by S Roedenbeck Breakdown of academic impact, for papers by Sueli Donizete Borelli Breakdown of academic impact, for papers by Henry F. Pabst Breakdown of academic impact, for papers by Imelda Lindo de Soriano Breakdown of academic impact, for papers by T. Gotlieb‐Stematsky
Rankless by CCL
2026